Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir + Ribavirin Pre-Transplant for HCV Recurrence Prevention
NCT01559844Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Mar 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of sofosbuvir in hepatitis C (HCV), sponsored by Gilead Sciences. Started Mar 2012; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01559844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01559844.